Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tyra Biosciences
Biotech
Tyra banks $173M to bring cancer resistance programs into clinic
Tyra is the latest biotech to rake in an upsized IPO. Its $172.8 million deal will advance three programs targeting drug-resistant cancers.
Amirah Al Idrus
Sep 15, 2021 10:20am
Tyra Biosciences wants to bank $100M for an IPO
Aug 23, 2021 7:05am
Tyra banks $106M, adds to C-suite as it aims for clinic in 2022
Mar 31, 2021 11:00am
